Bloom S R
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Gut. 1987;28 Suppl(Suppl):31-5. doi: 10.1136/gut.28.suppl.31.
The presence of a circulating factor affecting gut growth can be surmised from the findings in gut isolated from the main food stream and not under direct nutritional influence. Thus when a Thiry Vella fistula is constructed and the crypt cell production rate counted in the fistula it can be shown to correlate with the degree of resection of the main bowel left in continuity. The only hormones which become raised in a similar pattern are enteroglucagon and peptide tyrosine tyrosine (PYY). Enteroglucagon has been shown to be part of preproglucagon, which contains in addition oxyntomodulin, glucagon like peptide 1 1-37 and 6-36NH2 and glucagon like peptide 2. These form the main candidates for the 'hormone of gut growth'. Peptide tyrosine tyrosine has been tested by direct administration over 12 days, matching the natural rise, but no affect on crypt cell production rate was seen. Glucagon like peptide 1 1-37 was similarly tested and also found to produce no effect. It remains to test the other members of the glucagon family to confirm or refute the hypothesis that one of them is the enigmatic small gut growth factor.
从与主要食物流隔离且不受直接营养影响的肠道研究结果中,可以推测出存在一种影响肠道生长的循环因子。因此,当构建一个Thiry Vella瘘管并计算瘘管中的隐窝细胞生成率时,可发现其与连续保留的主要肠段的切除程度相关。以类似模式升高的唯一激素是肠高血糖素和酪酪肽(PYY)。肠高血糖素已被证明是前胰高血糖素的一部分,前胰高血糖素还包含胃泌酸调节素、胰高血糖素样肽1 1-37和6-36NH2以及胰高血糖素样肽2。这些构成了“肠道生长激素”的主要候选者。酪酪肽已通过12天的直接给药进行测试,剂量与自然升高水平相符,但未观察到对隐窝细胞生成率有影响。胰高血糖素样肽1 1-37也进行了类似测试,同样未发现有作用。仍有待测试胰高血糖素家族的其他成员,以证实或反驳其中之一是神秘的小肠生长因子这一假说。